Helena Santos
Chief Executive Officer bei SCIENTIFIC INDUSTRIES, INC.
Vermögen: 458 461 $ am 31.03.2024
Profil
Helena R.
Santos currently works at Scientific Industries, Inc., as President, Chief Executive Officer & Director from 2024 and Altamira Instruments, Inc., as President & Treasurer.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
17.01.2024 | 258 288 ( 3,69% ) | 458 461 $ | 31.03.2024 |
Aktive Positionen von Helena Santos
Unternehmen | Position | Beginn |
---|---|---|
SCIENTIFIC INDUSTRIES, INC. | Chief Executive Officer | 01.08.2002 |
Altamira Instruments, Inc.
Altamira Instruments, Inc. Medical SpecialtiesHealth Technology Altamira Instruments, Inc. manufactures catalyst characterization instrumentation and bench-scale micro-reactor systems for industrial and research use. Its products and services include: single and multi-station characterization systems from the AMI family; bench-scale, rack-mounted, catalytic micro-reactor systems from the BenchCAT line; pulse chemisorption; catalysis consulting and technical assistance to clients; high throughput reactor systems for catalyst screening from the BenchCAT-HTS family and Benchtop micro-reactor systems from the BenchCAT line. The company was founded in 1984 and is headquartered in Pittsburgh, PA. | President | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SCIENTIFIC INDUSTRIES, INC. | Producer Manufacturing |
Private Unternehmen | 1 |
---|---|
Altamira Instruments, Inc.
Altamira Instruments, Inc. Medical SpecialtiesHealth Technology Altamira Instruments, Inc. manufactures catalyst characterization instrumentation and bench-scale micro-reactor systems for industrial and research use. Its products and services include: single and multi-station characterization systems from the AMI family; bench-scale, rack-mounted, catalytic micro-reactor systems from the BenchCAT line; pulse chemisorption; catalysis consulting and technical assistance to clients; high throughput reactor systems for catalyst screening from the BenchCAT-HTS family and Benchtop micro-reactor systems from the BenchCAT line. The company was founded in 1984 and is headquartered in Pittsburgh, PA. | Health Technology |